Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
5.51
+0.17 (3.18%)
At close: Jan 17, 2025, 4:00 PM
5.67
+0.16 (2.85%)
After-hours: Jan 17, 2025, 7:57 PM EST
Jasper Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Jasper Therapeutics stock have an average target of 67.75, with a low estimate of 40 and a high estimate of 90. The average target predicts an increase of 1,129.58% from the current stock price of 5.51.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for JSPR stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 5 | 7 | 7 | 7 | 8 | 8 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Reiterates $70 | Buy | Reiterates | $70 | +1,170.42% | Jan 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +625.95% | Jan 10, 2025 |
RBC Capital | RBC Capital | Buy Maintains $68 → $48 | Buy | Maintains | $68 → $48 | +771.14% | Jan 9, 2025 |
JMP Securities | JMP Securities | Buy Maintains $70 | Buy | Maintains | $70 | +1,170.42% | Jan 6, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $68 | Buy | Reiterates | $68 | +1,134.12% | Dec 23, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
4.99M
EPS This Year
-4.66
from -6.18
EPS Next Year
-4.57
from -4.66
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | 46.2M | 10.5M | |||
Avg | n/a | 5.0M | 1.7M | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | 110.5% | |||
Avg | - | - | -66.8% | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -4.45 | -2.63 | -3.78 | |||
Avg | -4.66 | -4.57 | -4.90 | |||
Low | -5.04 | -6.42 | -6.23 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.